These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 27208561)
1. Aspirin resistance may be identified by miR-92a in plasma combined with platelet distribution width. Binderup HG; Houlind K; Madsen JS; Brasen CL Clin Biochem; 2016 Oct; 49(15):1167-1172. PubMed ID: 27208561 [TBL] [Abstract][Full Text] [Related]
2. Identification of aspirin resistance using a PDW-miR92a-score: Validation in an intermittent claudication cohort. Binderup HG; Houlind K; Brasen CL; Madsen JS Clin Biochem; 2019 Feb; 64():30-36. PubMed ID: 30586555 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis. Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216 [TBL] [Abstract][Full Text] [Related]
4. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays. Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet effect of aspirin in patients with coronary artery disease. Grove EL Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204 [TBL] [Abstract][Full Text] [Related]
6. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry. Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236 [TBL] [Abstract][Full Text] [Related]
7. Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort. Bolliger D; Filipovic M; Matt P; Tanaka KA; Gregor M; Zenklusen U; Seeberger MD; Lurati Buse G Platelets; 2016; 27(3):254-61. PubMed ID: 26367099 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
9. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469 [TBL] [Abstract][Full Text] [Related]
10. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease]. Wang H; Lu HM; Yang WH; Luo C; Lu SH; Zhou Y; Lin YZ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):215-8. PubMed ID: 22464573 [TBL] [Abstract][Full Text] [Related]
11. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors. Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257 [TBL] [Abstract][Full Text] [Related]
12. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. Tantry US; Bliden KP; Gurbel PA J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872 [TBL] [Abstract][Full Text] [Related]
13. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Chyrchel B; Totoń-Żurańska J; Kruszelnicka O; Chyrchel M; Mielecki W; Kołton-Wróż M; Wołkow P; Surdacki A Platelets; 2015; 26(6):593-7. PubMed ID: 25350775 [TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment. Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM Platelets; 2015; 26(8):783-7. PubMed ID: 25734355 [TBL] [Abstract][Full Text] [Related]
15. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
17. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727 [TBL] [Abstract][Full Text] [Related]
18. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. de Boer HC; van Solingen C; Prins J; Duijs JM; Huisman MV; Rabelink TJ; van Zonneveld AJ Eur Heart J; 2013 Nov; 34(44):3451-7. PubMed ID: 23386708 [TBL] [Abstract][Full Text] [Related]
19. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis. Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of miR-92a in asymptomatic carotid artery stenosis patients and its ability to predict cerebrovascular events. Chen G; Gao J; Sheng Y; Han X; Ji X; Zhao M; Wu J Diagn Pathol; 2020 Jun; 15(1):74. PubMed ID: 32522208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]